ProUroCare Medical (PUMD) Stock Price, News & Analysis

Company Overview

ProUroCare Medical, Inc. was a medical device company focused on developing technologies for the detection and evaluation of prostate disease, including prostate cancer. Its primary product was the ProUroScan system, an office-based imaging platform designed to help physicians identify and assess abnormalities in the prostate.

The ProUroScan technology used mechanical or tactile imaging to measure tissue characteristics and generate visual representations of the prostate. The system was intended to complement conventional diagnostic methods, such as digital rectal examinations, ultrasound and biopsy, by providing physicians with additional information during prostate evaluation.

Publicly available information about ProUroCare Medical’s current operations, geographic reach and leadership is limited. The company’s historical activities were centered on the development and commercialization of prostate-imaging technology for use by urologists and other medical professionals.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Today: 9/28/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: OTCMKTS:PUMD
• CIK: 1222244
• Web: www.prourocare.com
• Phone: (952) 476-9093
• Fax: 952-843-7031
• Employees: 2
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: 1.53